• Principles and modelling of pharmacokinetic and pharmacodynamic relationships - Graham Trevitt, XenoGesis
  • Understanding PK/PD using pre-clinical models: Lessons for efficacy studies - Jenny Worthington, AxisBio
  • Evaluation of clinical and pre-clinical pharmacodynamic endpoints using non-invasive imaging modalities - Neill Gingles, MDC

2pm BST, 27th May 2020

This webinar has already taken place

© Medicines Discovery Catapult 2020. All rights reserved. Read our Privacy Policy

About the presenters

Dr Graham Trevitt 

Graham is CSO and heads up the scientific team at XenoGesis. He joined XenoGesis in 2015, bringing over 14 years’ industrial drug discovery experience, as well as a track record of delivering pre-clinical drug candidates in oncology and inflammation through integration of DMPK properties into compound design to increase the probability of creating successful drugs. Prior to joining XenoGesis, Graham worked at UCB for 8 years before joining Almac Discovery in 2009. Graham graduated from the University of Nottingham with a PhD in Synthetic Organic Chemistry and went on to complete his Postdoctoral Research at the University of Geneva.